gut flora metabolism phosphatidylcholine promotes cardiovascular disease abstract metabolomics studies hold promise discovery pathways linked disease processes cardiovascular disease cvd represents leading death morbidity worldwide metabolomics approach generate unbiased small molecule metabolic profiles plasma predict risk cvd metabolites dietary lipid phosphatidylcholine choline trimethylamine n-oxide tmao betaine identified shown predict risk cvd independent large clinical cohort dietary supplementation mice choline tmao betaine promoted up-regulation multiple macrophage scavenger receptors linked atherosclerosis supplementation choline tmao promoted atherosclerosis studies germ-free mice confirmed critical role dietary choline gut flora tmao production augmented macrophage cholesterol accumulation foam cell formation suppression intestinal microflora atherosclerosis-prone mice inhibited dietary choline-enhanced atherosclerosis genetic variations controlling expression flavin monooxygenases fmos enzymatic source tmao segregated atherosclerosis hyperlipidemic mice discovery relationship gut flora-dependent metabolism dietary phosphatidylcholine cvd pathogenesis opportunities development diagnostic tests therapeutic approaches atherosclerotic heart disease 
